Avicanna Inc.
AVCN.TOTSXHealthcare● Active
$0.12
+$0.00(+0.00%)
Market Cap$14466065
P/E Ratio—
52W High$0.31
52W Low$0.11
Avicanna Inc. (AVCN.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVCN.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($2.84M) | ($3.62M) | ($8.74M) | ($14.74M) | ($16.77M) |
| Depreciation & Amort. | $0.74M | $0.85M | $0.78M | $0.89M | $0.89M |
| Stock-Based Comp. | $0.00M | $1.57M | $1.94M | $1.04M | $1.31M |
| Change in Working Capital | ($0.06M) | ($0.79M) | $4.36M | $1.43M | ($2.45M) |
| Net Cash from Operations | ($1.18M) | ($2.55M) | ($1.40M) | ($7.44M) | ($11.66M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.26M) | ($0.40M) | ($0.56M) | ($0.07M) | ($0.79M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | ($0.30M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.18M | $1.25M |
| Net Cash from Investing | ($0.26M) | ($0.40M) | ($3.05M) | $0.81M | $0.76M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.11M) | ($1.83M) | ($0.55M) | $0.06M | $0.95M |
| Net Cash from Financing | $0.96M | $3.41M | $3.55M | $9.90M | $10.06M |
| Free Cash Flow | |||||
| Free Cash Flow | ($1.44M) | ($2.95M) | ($1.96M) | ($7.50M) | ($12.45M) |
| FCF Margin %(computed) | -5.64% | -11.59% | -11.68% | -185.33% | -380.92% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M
Explore more Avicanna Inc. data
About Avicanna Inc. (AVCN.TO) Cash Flow Statement
Avicanna Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2025 — a FCF margin of -5.64%. Capital expenditure was ($0.00B).
Frequently asked questions
AVCN.TO · 4 questionsAvicanna Inc. generated free cash flow of ($0.00B) for 2025, up 51.3% year-over-year.
AVCN.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10